Vlad Ratziu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Glycemic Control

Top Venues

Hepatology communications

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Stephen A Harrison, Vlad Ratziu, Quentin Mark Anstee, Mazen Noureddin, Arun J Sanyal, Jörn Markus Schattenberg, Pierre Bedossa, Mustafa R Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V Kowdley, Zobair M Younossi, Rohit Loomba
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Juan Manuel Pericàs, Nicholas A Di Prospero, Quentin Mark Anstee, Peter Mesenbrinck, Mette S Kjaer, Jesus Manuel Rivera Esteban, Franz Koenig, Elena Sena, Raluca Pais, Ramiro Manzano, Joan Genescà, Frank Tacke, Vlad Ratziu, null null
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials. Alimentary pharmacology & therapeutics (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Raluca Pais, Judith Aron-Wisnewsky, Pierre Bedossa, Maharajah Ponnaiah, Jean-Michel Oppert, Jean-Michel Siksik, Laurent Genser, Frederic Charlotte, Dominique Thabut, Karine Clement, Vlad Ratziu
Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery. Hepatology (Baltimore, Md.) 76 (2) (2022)
Rish K Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A Adeyi, Quentin Mark Anstee, Bashar A Aqel, Cynthia Behling, Elizabeth J Carey, Andrew D Clouston, Kathleen E Corey, Brian G Feagan, David E Kleiner, Christopher Ma, Stefanie C McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A Valasek, Zobair M Younossi, Stephen A Harrison, Stephen Caldwell
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology (Baltimore, Md.) 76 (4) (2022)
Vlad Ratziu, Raluca Pais
Editorial: it is not a wide-open field for incretins - collateral benefits favour the use of metformin in advanced non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics 50 (5) (2020)